BridgeMD
New treatment option for Extra Uterine Growth Restriction
Official title Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
ClinicalTrials.gov ID: NCT06731439
What this study is testing
- What it's testing
- Feeding advancements in ELBW infants have evolved over decades. The fear of causing mortality and morbidity, notably NEC, have made providers cautious when advancing feeds.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 6
You may be able to join if
- All infants less than or equal to 1000 g
- Clinical care team in agreement with patient's participation
- All mothers with pregnancies with EFW close to 1000g or less.
You likely can't join if
- 1 congenital malformations that may affect gastro intestinal perfusion
- 2 Clinically progressing towards imminent death
- 3 congenital gastrointestinal obstructions
- 4 Mothers unlikely to deliver infants ≤ 1000g
- 5 Infant on pressors other than dopamine given at \< 5mcg/kg/min. Dopamine is an exclusion if administered at a dose exceeding 5mcg/kg/min.
- 6 Mothers who are not in a sound mental state to be consented either to their critical condition, intubated, sedated, for examples
See the full eligibility criteria
- All infants less than or equal to 1000 g
- Clinical care team in agreement with patient's participation
- All mothers with pregnancies with EFW close to 1000g or less.
- 1 congenital malformations that may affect gastro intestinal perfusion
- 2 Clinically progressing towards imminent death
- 3 congenital gastrointestinal obstructions
- 4 Mothers unlikely to deliver infants ≤ 1000g
- 5 Infant on pressors other than dopamine given at \< 5mcg/kg/min. Dopamine is an exclusion if administered at a dose exceeding 5mcg/kg/min.
- 6 Mothers who are not in a sound mental state to be consented either to their critical condition, intubated, sedated, for examples
- 7 Mothers who are critically ill where by it is felt that mom will not be able to participate in the consent
The study team makes the final eligibility decision.
Where it's taking place
- Memphis, Tennessee, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 minute to 6 hours. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.